[Peritoneal tuberculosis in a patient with chronic lymphatic leukemia in treatment with fludarabine].
Albo
C
C
Benítez
E
E
Constenla
M I
MI
Plaza
J
J
Poderós
C
C
D000243:Adenosine Deaminase / Q000097:blood; D000368:Aged; D015415:Biomarkers; D005188:False Negative Reactions; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000150:complications* / Q000276:immunology; D014395:Peritonitis, Tuberculous / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D014374:Tuberculin Test; D001084:Vidarabine Phosphate / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D015415:Biomarkers; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D000243:Adenosine Deaminase
Tuberculosis peritoneal en paciente con leucemia linfática crónica en tratamiento con fludarabina.